BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17850589)

  • 1. Capture of membrane components via trogocytosis occurs in vivo during both dendritic cells and target cells encounter by CD8(+) T cells.
    Riond J; Elhmouzi J; Hudrisier D; Gairin JE
    Scand J Immunol; 2007 Oct; 66(4):441-50. PubMed ID: 17850589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced antigen concentration and costimulatory blockade increase IFN-gamma secretion in naive CD8+ T cells.
    Hall HT; Petrovic J; Höglund P
    Eur J Immunol; 2004 Nov; 34(11):3091-101. PubMed ID: 15384046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells acquire cell surface determinants of APC via in vivo trogocytosis during viral infections.
    Rosenits K; Keppler SJ; Vucikuja S; Aichele P
    Eur J Immunol; 2010 Dec; 40(12):3450-7. PubMed ID: 21080375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis.
    Hudrisier D; Clemenceau B; Balor S; Daubeuf S; Magdeleine E; Daëron M; Bruhns P; Vié H
    J Immunol; 2009 Nov; 183(10):6102-13. PubMed ID: 19841164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells down-modulate peptide-MHC complexes on APCs in vivo.
    Kedl RM; Schaefer BC; Kappler JW; Marrack P
    Nat Immunol; 2002 Jan; 3(1):27-32. PubMed ID: 11731800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical labels metabolically installed into the glycoconjugates of the target cell surface can be used to track lymphocyte/target cell interplay via trogocytosis: comparisons with lipophilic dyes and biotin.
    Daubeuf S; Aucher A; Sampathkumar SG; Preville X; Yarema KJ; Hudrisier D
    Immunol Invest; 2007; 36(5-6):687-712. PubMed ID: 18161525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.
    O'Beirne J; Mitchell J; Farzaneh F; Harrison PM
    Virology; 2009 Jun; 389(1-2):1-7. PubMed ID: 19409594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining.
    Pang KC; Wei JQ; Chen W
    J Immunol Methods; 2006 Apr; 311(1-2):12-8. PubMed ID: 16516224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early cytoskeletal rearrangement during dendritic cell maturation enhances synapse formation and Ca(2+) signaling in CD8(+) T cells.
    Averbeck M; Braun T; Pfeifer G; Sleeman J; Dudda J; Martin SF; Kremer B; Aktories K; Simon JC; Termeer C
    Eur J Immunol; 2004 Oct; 34(10):2708-19. PubMed ID: 15368287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells.
    Hudrisier D; Riond J; Garidou L; Duthoit C; Joly E
    Eur J Immunol; 2005 Aug; 35(8):2284-94. PubMed ID: 16021601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
    Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
    Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
    J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen bias in T cell cross-priming.
    Wolkers MC; Brouwenstijn N; Bakker AH; Toebes M; Schumacher TN
    Science; 2004 May; 304(5675):1314-7. PubMed ID: 15166378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells.
    Schildberg FA; Hegenbarth SI; Schumak B; Scholz K; Limmer A; Knolle PA
    Eur J Immunol; 2008 Apr; 38(4):957-67. PubMed ID: 18383043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions.
    Stelekati E; Bahri R; D'Orlando O; Orinska Z; Mittrücker HW; Langenhaun R; Glatzel M; Bollinger A; Paus R; Bulfone-Paus S
    Immunity; 2009 Oct; 31(4):665-76. PubMed ID: 19818652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DC-induced CD8(+) T-cell response is inhibited by MHC class II-dependent DX5(+)CD4(+) Treg.
    Han WG; Schuurhuis DH; Fu N; Camps M; van Duivenvoorde LM; Louis-Plence P; Franken KL; Huizinga TW; Melief CJ; Toes RE; Ossendorp F
    Eur J Immunol; 2009 Jul; 39(7):1765-73. PubMed ID: 19544486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.